Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore models

Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore models Synthesis and Evaluation of the Affinity toward μ-Opioid Receptors of Atypical, Lipophilic Ligands Based on the Sequencec[-Tyr-Pro-Trp-Phe-Gly-] Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands Design, synthesis, and binding characteristics of an opiate receptor mimetic peptide Design, Synthesis, and Evaluation of Opioid Analogues with Non-Peptidic β-Turn Scaffold:  Enkephalin and Endomorphin Mimetics Identification of the three-dimensional pharmacophore of κ-opioid receptor agonists Peptides as receptor selectivity modulators of opiate pharmacophores Synthesis, Biological Evaluation, and Automated Docking of Constrained Analogues of the Opioid Peptide H-Dmt-<scp>d</scp>-Ala-Phe-Gly-NH₂Using the 4- or 5-Methyl Substituted 4-Amino-1,2,4,5-tetrahydro-2-benzazepin-3-one Scaffold Synthesis and activity profiles of new dermorphin-(1-4) peptide analogs Morphiceptin Analogues Containing a Dipeptide Mimetic Structure:  An Investigation on the Bioactive Topology at the μ-Receptor